Texts of Orchard Response and Questions regarding the Bubble Baby Treatment plus Related SEC Filings (August 2021)
Below are the questions posed to Orchard by the California Stem Cell Report and the company’s response. The company did not respond to all the questions. Also below is what Orchard had to say about the OTL-101 treatment in its most recent quarterly filing with the U.S. Securities and Exchange Commission. (See here for full story.)
California Stem Cell …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.